Latest News
Bluejay Diagnostics Stock Surges 171% on U.S. Manufacturing Deal, FDA Hurdle Remains
Bluejay Diagnostics shares surged 171% to $5.88 after announcing a U.S. manufacturing partnership for its Symphony sepsis-testing platform, but the stock faces risks from pending FDA clearance and ongoing capital needs.
Gaxos.ai Surges 57% on AWS Investment in AI Sales Platform
Gaxos.ai shares surged 57% to $1.87 on record volume after AWS disclosed further investment in its AI sales-coaching platform, though deal specifics remain undisclosed.
Shake Shack Stock Plunges 10% on Outlook Cut Amid Demand Woes
Shake Shack shares dropped 10.3% after slashing Q2 and 2026 outlooks, citing macroeconomic uncertainty and competition. Revenue and margin forecasts were cut.
Decent Holding Surges 159% After Chairman Buys $800K in Shares
Decent Holding Inc. shares surged 159% to $4.14 after Chairman Dingxin Sun bought 400,000 Class B shares at $2 each, increasing his voting power to about 90.5% and sparking heavy trading.
Nu Holdings Slips on BofA Downgrade Amid CFO Departure and Brazil Credit Concerns
Nu Holdings dropped 6.3% after BofA downgraded the stock to Underperform, citing CFO Guilherme Lago's departure and rising credit risks in Brazil. New CFO Rob Livingston will take over on July 13.
AI Memory Boom Drives DRAM ETF to $13.4 Billion in First Two Months
Roundhill Memory ETF (DRAM) saw $553.7 million in new inflows on May 29, pushing assets to $13.36 billion, as investors pile into AI-memory exposure. The fund focuses on high-bandwidth memory, DRAM, and NAND stocks.
IBM Shares Cool After Quantum, Barclays, and Retail Rally
IBM shares eased 0.4% to $319.10 after hitting a high of $327.22, as investors weighed a $10B quantum computing plan, a Barclays upgrade, and a $1B CHIPS-funded foundry. Retail trading spiked but risks persist.
